What Is Denial Management?
Denial management is the operational discipline of categorizing, appealing, and preventing denied claims using the X12 835 CARC/RARC taxonomy: eligibility (CARC 27, 31), prior authorization (CARC 197), medical necessity (CARC 50), bundling/NCCI (CARC 97, 236), modifier issues (CARC 4), and timely filing (CARC 29). HFMA reports 65% of denied claims are never appealed industry-wide despite 50-70% being overturnable. MedPrecision categorizes every denial within 24 hours and routes it to a payer-specific appeal strategy.
- Average appeal overturn rate: 72% (vs. industry 40-50%)
- Targets denial rate under 5% within 90 days
- Appeals filed inside 60-90-day payer timely-filing window
- Recurring denial patterns trigger upstream prevention same week
Denial Management Services
Claim denials cost the average practice 3-5% of net revenue. MedPrecision's denial management team identifies root causes, manages appeals, and implements preventive measures to stop denials before they happen.
Most practices accept denials as a cost of doing business, but the majority of denied claims are recoverable with the right approach. MedPrecision's denial management services go beyond simple resubmission -- we analyze denial patterns to identify root causes, craft compelling appeals with supporting documentation, and implement upstream fixes that prevent the same denials from recurring. Our systematic approach turns denials from a revenue drain into a manageable, shrinking problem.
Who This Service Is For
The State of Denial Management Services in 2026
According to KFF analysis of CMS data, Medicare fee-for-service claim denial rates average 16.6%, while Medicare Advantage plans deny claims at rates ranging from 5% to over 18% depending on the insurer. MGMA's 2024 benchmarking report found that the median physician practice denial rate is 6.8%, but practices in the top quartile maintain rates below 4%. HFMA estimates that 65% of denied claims are never appealed, representing billions in recoverable revenue abandoned annually across the healthcare industry. The AMA's 2024 Prior Authorization Survey found that 34% of physicians reported that prior authorization led to a serious adverse event for a patient, highlighting the operational and clinical impact of authorization-related denials. Advisory Board research shows that the average cost to appeal a denied claim is $118, making strategic appeal prioritization essential. Practices that implement systematic denial management programs typically reduce their denial rates by 50-70% within the first year according to HFMA's Revenue Cycle Improvement guide. CMS has proposed new rules requiring Medicare Advantage plans to disclose denial rates and overturn rates, which may increase transparency and accountability in payer denial practices.
What Is Breaking Right Now
High denial rates eroding 3-5% or more of net revenue annually
Lack of visibility into denial root causes making prevention impossible
Denied claims going unworked due to limited staff resources and expertise
Recurring denials from the same systemic issues that are never addressed
Low appeal overturn rates from poorly crafted or untimely appeal submissions
Common Denial Management Services Mistakes to Avoid
Not tracking denial reason codes systematically
Without categorized denial data, practices cannot identify patterns or implement preventive measures, leading to the same denials recurring month after month.
Implement a denial taxonomy that categorizes every denial by root cause (eligibility, coding, authorization, documentation) and track trends monthly with specific prevention actions for each category.
Accepting initial denials without appealing
HFMA data shows that 65% of denied claims are never appealed, yet 50-70% of appealed claims are overturned. Practices that do not appeal are surrendering recoverable revenue.
Establish a policy to appeal every denial with a reasonable probability of overturn. Use historical overturn rates by payer and denial category to prioritize appeal efforts.
Filing generic appeal letters without payer-specific evidence
Generic appeals have significantly lower overturn rates because they do not address the specific clinical, contractual, or regulatory arguments that each payer's review process evaluates.
Develop payer-specific appeal templates that include the exact documentation, clinical evidence, contract language, and regulatory citations each payer responds to most favorably.
Treating denial management as a back-end process only
By the time a claim is denied, the cost to resolve it is 5-10 times higher than preventing it. Practices that focus only on appeals without fixing upstream causes never reduce their denial rates.
Connect denial trend data to upstream process owners in real time. Every recurring denial pattern should trigger a specific process change in registration, authorization, coding, or documentation within the same month.
Missing payer appeal filing deadlines
Most payers allow only 60-90 days from the date of the denial to file an appeal. Missing this window forfeits the right to appeal and makes the denial permanent.
Implement automated appeal deadline tracking with escalation alerts at 30 days and 15 days before expiration. Prioritize appeals nearing their deadline regardless of other factors.
What We Handle
Denial Pattern Analysis
Advanced analytics identify your top denial reasons by payer, provider, service type, and reason code to focus prevention efforts where they will have the most impact.
Appeal Preparation & Submission
Expertly crafted appeal letters with supporting clinical documentation, payer contract references, and regulatory citations to increase overturn rates.
Preventive Denial Strategies
Root cause analysis findings are translated into actionable process changes in coding, registration, and authorization to prevent denials at the source.
Multi-Level Appeal Management
We manage the full appeal lifecycle from first-level reconsideration through external review and state insurance department complaints when warranted.
Denial Rate Benchmarking
Track your denial rates against specialty and payer benchmarks to measure improvement and identify areas that still need attention.
Our Denial Management Services Methodology
Denial Taxonomy Classification
Every denial is coded into a multi-level taxonomy that categorizes it by root cause (eligibility, coding, authorization, documentation, payer error), subcategory (specific denial reason), and responsible process area. This classification enables precise targeting of prevention efforts rather than broad, ineffective corrective actions.
Payer-Specific Appeal Strategy Development
Each payer has different appeal requirements, timelines, documentation preferences, and decision-making patterns. We develop payer-specific appeal templates, evidence packages, and escalation paths that are proven to increase overturn rates for each payer rather than using generic appeal letters.
Clinical Documentation Enhancement
For medical necessity denials, we work directly with clinical staff to strengthen documentation that supports the services billed. This includes specific language recommendations, peer-reviewed literature citations, and clinical guideline references that payer medical directors expect to see in appeal documentation.
Root Cause Prevention Implementation
Denial trends are translated into specific, measurable process changes in upstream workflows. If authorization-related denials are rising, the prior authorization process is audited and corrected. If coding denials spike for a specific CPT, the coding team receives targeted education. Prevention is always more cost-effective than appeals.
Multi-Level Appeal Escalation
When first-level appeals are unsuccessful, we systematically escalate through each available level: reconsideration, formal appeal, independent external review, and state insurance department complaints. Each escalation level uses progressively stronger evidence and legal arguments configured to the reviewing body.
Denial Recovery Forecasting
Using historical overturn rates by payer and denial category, we provide monthly recovery forecasts that predict how much denied revenue is likely to be recovered. This enables accurate financial planning rather than hoping appeals will succeed.
Real Results
The Challenge
Denial rate had climbed to 22% driven primarily by prior authorization failures and medical necessity denials for advanced imaging and surgical procedures. The practice was losing an estimated $45,000 per month in unrecovered denied claims.
Our Approach
MedPrecision deployed a denial taxonomy analysis that categorized every active denial by root cause. We discovered that 58% of denials stemmed from three preventable categories: missing prior authorizations for MRI and CT procedures, insufficient documentation of medical necessity for elective surgeries, and incorrect modifier usage on bilateral procedures. We implemented upstream fixes for each category while simultaneously working the existing denial backlog.
Key Outcomes
- check_circle Denial rate reduced from 22% to 3.8% within 90 days
- check_circle Net collections increased by $340,000 annually from recovered denials
- check_circle Average days in A/R dropped from 52 to 29 as denial-related holds cleared
- check_circle Prior authorization compliance reached 99.7% through integrated verification
“We had no idea how much we were leaving on the table until MedPrecision showed us the data. Over $340,000 in annual revenue was being lost to preventable denials that nobody was tracking.”
Denial Management Services: MedPrecision vs Alternatives
| Feature | MedPrecision | In-House | Other Providers |
|---|---|---|---|
| Denial Root Cause Analysis | Automated and manual review with coded taxonomy tracking every denial by root cause category | Ad-hoc review when staff has time, no systematic categorization | Basic denial reason code reports without root cause depth |
| Appeal Documentation Quality | Payer-specific templates with clinical evidence, contract references, and regulatory citations | Generic appeal letters with minimal supporting documentation | Standard templates with some customization per denial type |
| Prevention Strategy | Weekly denial trend analysis fed directly to coding, authorization, and registration teams | Rarely connected to upstream process improvement | Quarterly denial trend reports with general recommendations |
| Multi-Level Appeal Management | Systematic escalation through all available appeal levels including external review | Typically stops after first-level appeal | Manages first and second-level appeals, limited external review experience |
| Government Payer Expertise | Specialized staff for Medicare Redetermination, QIC, ALJ, and Medicaid fair hearing processes | Limited knowledge of government appeal processes | General appeal process applied to all payers |
| Recovery Tracking | Claim-level tracking with dollar recovery by denial category, payer, and appeal level | Aggregate denial and recovery numbers without detailed breakdowns | Monthly recovery reports with limited granularity |
| Denial Rate Benchmarking | Specialty-specific benchmarks from MGMA and internal client data | No external benchmarking capability | Generic industry benchmarks not specialty-adjusted |
“The practices that see the biggest improvement in collections are the ones that commit to weekly denial review meetings. It is not enough to appeal -- you have to prevent. For every dollar we spend on denial prevention, we save eight dollars in appeal costs and recovered revenue.”
MedPrecision Billing Team
Director of Revenue Cycle Operations
How the Transition Works
How we deliver denial management services for your practice.
Denial Inventory & Root Cause Analysis
We categorize all current denials by type (clinical, technical, administrative) and identify the root causes driving each denial category.
Appeal Strategy & Execution
Each denial is assigned an appeal strategy based on the denial reason, payer, and recovery probability. Appeals are submitted within payer timelines with full supporting documentation.
Prevention Implementation
Root cause findings are used to implement process changes in front-end operations, coding practices, and claim submission workflows to prevent recurring denials.
Monitoring & Continuous Improvement
Denial rates are tracked weekly by category and payer. Prevention measures are validated against actual denial trends, and strategies are adjusted based on results.
What Reporting and Visibility Looks Like
Transparency is built into every engagement. You will always know where your revenue stands and what actions are being taken on your behalf.
Monthly KPI Dashboards
Track collection rates, denial trends, days in A/R, and payer-level performance with dashboards delivered on a fixed schedule.
Real-Time Claim Tracking
See claim status updates in real time so you never have to wonder where a payment stands or when follow-up is happening.
Quarterly Business Reviews
Detailed reviews with actionable recommendations covering denial root causes, payer trends, and revenue recovery opportunities.
Proactive Alerts
Automated alerts when key metrics shift, so issues are caught and addressed before they affect your bottom line.
Denial Management Services Key Terms
- Clean Claim Rate
- The percentage of claims accepted by payers on first submission without requiring correction, resubmission, or additional information. Industry benchmark is 95% or higher.
- Denial Rate
- The percentage of submitted claims that are denied by payers. Calculated by dividing total denied claims by total submitted claims. MGMA benchmark for well-managed practices is below 5%.
- Appeal Overturn Rate
- The percentage of appealed denials that are reversed and paid by the payer. Industry average is 40-50%. Well-managed denial programs achieve 65-75%.
- CARC/RARC Codes
- Claim Adjustment Reason Codes and Remittance Advice Remark Codes. Standardized codes on remittance advices that explain why a claim was adjusted, denied, or paid differently than billed. Essential for denial categorization and trending.
- Medical Necessity Denial
- A payer's determination that the service billed was not medically necessary based on their clinical coverage criteria. These denials typically require clinical documentation and peer-reviewed evidence to overturn on appeal.
- External Review
- An independent review of a denied claim by a third-party organization not affiliated with the payer. Available in most states for certain denial types after internal appeal options are exhausted. External reviewers overturn payer denials approximately 40-50% of the time.
- Preventable Denial
- A denial that could have been avoided through proper front-end processes such as eligibility verification, prior authorization, accurate coding, or complete documentation. Industry data suggests 60-70% of all denials are preventable.
Common Questions
Common questions about denial management services.
Get a Free Billing Audit
See where denials, follow-up delays, or workflow gaps may be hurting your collections.
Get a Free Billing Audit arrow_forwardWhat is your average appeal overturn rate?
Well-managed denial management programs achieve appeal overturn rates of 65-75%, compared to the industry average of 40-50% reported by HFMA's Revenue Cycle Improvement guide. MedPrecision's portfolio averages 72% across all appealed denials, with first-level resolution at 78%. Overturn rates vary by denial category: medical necessity denials (CARC 50) overturn at roughly 55-65% when supported by peer-reviewed clinical literature and payer-specific medical policy citations, prior authorization denials (CARC 197) overturn at 70-80% when retrospective auth can be obtained, and bundling denials (CARC 97) overturn at 80-90% when proper modifier 59 or X-modifier (XE, XS, XP, XU) documentation is supplied. The differential between industry-average and best-practice overturn rates is driven by three factors: payer-specific appeal templates rather than generic letters, complete clinical documentation packages including operative notes and lab results, and systematic escalation through reconsideration, formal appeal, and external independent review when warranted.
What are the most common types of claim denials?
The five most common denial categories across U.S. Physician practices, as classified by X12 835 Claim Adjustment Reason Codes, are: (1) eligibility denials (CARC 27, 31) where coverage was terminated or the patient was assigned to a different payer, accounting for 15-20% of denials per HFMA benchmarks; (2) prior authorization denials (CARC 197), which the AMA's 2024 Prior Authorization Survey found increased significantly with 34% of physicians reporting a serious adverse event tied to auth delays; (3) medical necessity denials (CARC 50) requiring clinical documentation per the payer's medical policy; (4) coding denials including NCCI bundling (CARC 97, 236) and modifier issues (CARC 4), which cluster around CPT codes with frequent edit pairs; and (5) timely filing denials (CARC 29) when claims miss the payer's filing window of 90-365 days. Advisory Board research shows the average cost to appeal a denied claim is $118, making prevention 5-10 times more cost-effective than appeal.
How quickly do you start working on denied claims?
Denials are identified, categorized by CARC/RARC code, and entered into a workqueue within 24 hours of ERA (835) payment posting. High-priority denials, defined as those exceeding $1,000 in billed charges or those within 30 days of the payer's appeal filing deadline, are assigned to a senior appeals specialist the same business day. All denials enter active work within 5 business days of identification. This timeline matters because most commercial payers allow only 60-90 days from the date of the denial to file a first-level appeal; missing this window forfeits the right to appeal and makes the denial permanent. Medicare Part B allows 120 days for Redetermination requests under 42 CFR 405.942, which is more generous but still requires systematic deadline tracking. HFMA data indicates that 65% of denied claims are never appealed, meaning practices without disciplined denial workflows abandon billions of dollars in recoverable revenue annually.
Can you help with Medicare and Medicaid denials specifically?
Government payer denials follow distinct appeal pathways that differ substantially from commercial appeals and require specialized expertise. The Medicare appeals process has five levels under 42 CFR Part 405 Subpart I: (1) Redetermination by the Medicare Administrative Contractor within 60 days of the initial determination, (2) Reconsideration by a Qualified Independent Contractor (QIC), (3) Administrative Law Judge (ALJ) hearing for amounts in controversy above $190 (2024 threshold), (4) Medicare Appeals Council review, and (5) federal district court review. Medicare Advantage denials follow a separate but parallel process under 42 CFR 422 Subpart M. Medicaid appeals vary by state but generally include a fair hearing process under 42 CFR 431 Subpart E with state-specific timelines. According to KFF analysis of CMS data, Medicare Advantage plans deny claims at rates ranging from 5% to over 18% depending on the insurer, and CMS has proposed new transparency rules requiring disclosure of denial and overturn rates.
Related Services
Specialties We Serve
Related Resources
Available In
Get a Free Billing Audit
Let us analyze your denial patterns and show you exactly why claims are being rejected. Our audit identifies root causes so you can stop the bleeding.